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Background: (-)-Depudecin is a fungal metabolite that 
reverts the rounded phenotype of NIH3T3 fibroblasts 
transformed with v-ras and v-src oncogenes to the flat phe- 
notype of the nontransformed parental cells. The mecha- 
nism of action of this detransformation agent is unknown. 
Although depudecin appears to be an excellent molecule 
for probing signaling pathways that regulate changes in the 
cytoskeletal architecture, reagents based on depudecin are 
not available as it has not yet been successfully synthesized. 
We therefore set out to synthesize (-)-depudecin. 
Results: An asymmetric synthesis of (-)-depudecin has 
been developed. A cell staining assay has been used to 
reveal the ability of synthetic depudecin, but not several 
structural variants, to induce a flattened morphology in 
v-Ha-rar-transformed NIH3T3 ceIIs.This assay also shows 
that depudecin induces an intricate network of actin 
stress fibers in these cells and in MG63 osteosarcoma cells 
and reveals the essential role of the epoxide and hydroxyl 
moieties in depudecin. Cycloheximide and actinomycin 
D inhibited the ability of depudecin to induce a morpho- 
logical change, suggesting that both mRNA synthesis and 
de ~OVO protein synthesis are required for depudecin- 
mediated suppression of the transformed phenotypes in 
ras-transformed cells. 
Conclusions: The synthetic procedure provides access to 
(-)-depudecin and could be readily modified to produce 
depudecin-related reagents for the identification of 
depudecin’s cellular target(s). This target appears to be 
involved in the regulation of the assembly of the actin micro- 
filament component of the cytoskeleton in mammalian cells. 
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Introduction 
Natural products have been used to study the cellular 
functions of proteins in several ways. By identifying the 
cellular receptors for these compounds, new proteins 
have been discovered with functions linked to the 
effects the natural products have on cells [1,2]. When 
the receptors have been identified, and when it has 
been established that their binding interactions are spe- 
cific, the natural products have been used to reveal 
whether their targets are involved in specific cellular 
processes [3]. Mutations in the receptors that prevent 
natural-product binding, but that do not otherwise 
inhibit the actions of the receptors, have proven to be 
especially useful. Here, the role of residues and domains 
in the mutant receptors can be examined by perform- 
ing assays in the presence of the natural product and 
the mutant receptors. In this context, the natural 
product can be viewed as a chemical equivalent to a 
conditional loss-of-function allele in that it condition- 
ally inhibits the wild-type, endogenous receptor ([4] 
and Brown, E.J., Beal, PJ., Chen, J., Shin,T.B. & S.L.S., 
unpublished data). 
A fascinating class of natural products with detrans- 
forming properties may be especially illuminating as 
probes of cellular signaling pathways. Examples of such 
compounds include trapoxin A [5], herbimycin A [6], 
radicicol [7], and azatyrosine [8] _ These compounds are 
able to revert the morphological changes seen following 
transformation of cells in culture with either v-s& v-src, 
or v-m oncogenes. Although some of these agents have 
been shown to interact with the oncogene products 
directly, others act indirectly and many of their effects 
are still poorly understood. The molecular characteriza- 
tion of their actions in cells promises to illuminate these 
oncogene-mediated signaling pathways. 
Another example of this class of molecules is 
(-)-depudecin (compound 1, Fig. l), whose mechanism 
of detransformation action is completely obscure [9, lo]. 
Depudecin was discovered in the culture broth of the 
fungus Alternaria brassicicola using an assay for the mor- 
phological detransformation of NIH3T3 cells doubly 
transfected with v-rax and v-src oncogenes [9,10]. An 
X-ray crystallographic study of a depudecin derivative 
revealed its unprecedented structure, which consists of a 
highly oxidized 1 l-carbon chain containing two epoxides 
conjugated through a trans-disubstituted olefin.The puri- 
fied compound was reported to induce the flat pheno- 
type at concentrations lower than that required to inhibit 
proliferation of the same cells. On this basis, we selected 
depudecin as a molecule to probe signaling pathways that 
regulate the cytoskeletal architecture. As depudecin has 
not been synthesized previously and is not easily obtained 
otherwise, we initiated our studies by developing a total 
synthesis of (-)-depudecin. Using synthetic molecules 
including (-)-depudecin, we also initiated studies of the 
depudecin-sensitive step in transformed cells. Simple 
modifications of the synthesis should provide access to 
depudecin-based reagents useful for the identification of 
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interacting proteins and for the further dissection of the 
depudecin-sensitive signaling pathway. 
Results and discussion 
Our synthetic strategy to generate the sensitive bis-truns- 
epoxide moiety of compound 1 uses a one-pot procedure 
for the stereoselective conversion of syn-vicinal diols into 
truns-epoxides developed by Sharpless and others [ll-141. 
The synthesis of tetraol 19, a key intermediate that con- 
tains the entire depudecin skeleton, is summarized in Figs 
1 and 2. Methylenation of a D-threose derivative 2 [ 151, 
tevt-butyl dimethylsilyl (TBDMS) deprotection with tetra- 
butyl ammonium fluoride (TBAF), and subsequent Swern 
oxidation gave aldehyde 5 [16]. To achieve a one carbon 
homologation, compound 5 was reacted with 
2-trimethylsilylthiazole to afford anti-alcohol 6, which was 
then converted into the desired syn diastereomer 8 
through an oxidation-reduction sequence [17-l 91. The 
syn isomer was obtained selectively (4:l) using NaBH1; 
the more bulky reducing agent, K-Selectride, failed to 
improve the selectivity. The initial formation of isomer 6 is 
consistent with previous demonstrations that 
2-trimethylsilylthiazole reacts with cx,P-dialkoxy aldehy- 
des in a non-chelation manner to give the anti-alcohol 
[17]. Furthermore, the relative chemical shifts of newly 
formed hydroxyl-stereocenters in compounds 6 and 8 
support the assigned stereochemistry.The methine protons 
of these centers in anti-isomers usually have chemical shifts 
downfield of those in syn-isomers [ 171. The corresponding 
chemical shifts of compounds 6 and 8 are 65.27 and 4.97 
respectively. After TBDMS protection of the hydroxyl 
group, the aldehyde 10 (80 % isomeric purity) was 
released by cleavage of the thiazole ring [2O] using stan- 
dard procedures involving N-methylation, reduction with 
NaBH, and copper-assisted hydrolysis (Fig. 1). 
Ketophosphonate 12, which was synthesized [21] from 
ester 11 [22], was condensed with aldehyde 10 to yield 
enone 13 in 88 % yield. Sodium borohydride reduction 
in the presence of cerium chloride [23] yielded the 
desired non-chelation product 14 in 96 % yield. The 
reduction proceeded in about 90 % diastereoselectivity 
as determined by ‘H NMR. Deprotection of the silyl 
group followed by flash chromatography afforded diol 
15 in isomerically pure form. ‘H NMR coupling con- 
stants IJCJHpCjH, Jc6H-C7H) between the olefinic 
protons (C5H and C6H) of 15 and their adjacent 
methine protons (C4H and C7H) are similar in value, 
suggesting that the assigned stereochemistry of 15 is 
correct (pseudo-C2 symmetry). To elaborate tetraol 19 
from 15, we planned to synthesize a bis-cyclic carbonate 
17 as a key intermediate. Treatment of diol 15 with 
2,2,2-trichloroethyl chloroformate in the presence of 
2,6-lutidine, followed by treatment with anhydrous 
methanolic hydrochloride for 6 h gave the bis-carbonate 
derivative 17 in 44 % yield. Compound 17 isomerizes 
to an inseparable mixture of five- and six-membered 
bis-carbonates, even in neutral media (MeOH solution, 
-15 mM, 30 % isomerization at 23 “C, 16 h). Isolation 
of the labile intermediate 17 was facilitated by the reac- 
tivity of the 2,2,2-trichloroethyl carbonate relative to 
other carbonates examined, that is, methyl carbonate 
and p-nitrophenyl carbonate, and by the increased stabil- 
ity of 17 in acidic media. Treatment of compound 17 
with a large excess of dimethyl sulfide in the presence of 
benzoyl peroxide [24] gave bis-methylthiomethyl-pro- 
tected carbonate 18 in 34 % yield. Basic hydrolysis of 18 
gave the tetraol 19 (Fig. 2). 
Treatment of compound 19 with trimethylorthoacetate 
in the presence of catalytic pyridinium pdru-toluenesul- 
fonate (PPTS) followed by trimethylsilyl chloride in a tri- 
ethylamine buffer [14] gave diacetoxy dichloride 20 
exclusively.The crude product 20 was then subjected to 
base-mediated saponification resulting in spontaneous 
cyclization to furnish bis-truns epoxide 21 in 74 % overall 
2 3 R = TBDMS 5 6 
4R=H 
7 8R=H 10 
9 R = TBDMS 
Fig. 1. Synthesis of the aldehyde 10, 
representing the left part of depudecin 
1. Reagents and conditions: (a) 
Ph,P+Mel-, te&BuOK, 23 “C; (b) TBAF, 
tetrahydrofuran (THF), 23 “C; (c) Swern 
oxidation; (d) 2-trimethylsilylthiazole, 
THF, 23 “C, then TBAF; (e) Swern oxida- 
tion; (f) NaBH,, MeOH, -78 “C --t -20 
“C; (g) TBDMSCi, imidazole, dimethyl 
formamide (DMF), 70 “C; (h) Mel, 
MeCN, reflux; NaBH,; then CuO, 
CuCI,, MeCN-HZO. 
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Fig. 2. Synthesis of tetraol 19, a key inter- 
mediate that contains the complete 
depudecin 1 framework. Reagents and 
conditions: (a) LiCHzP(O)(OMe),, THF, 
0 “C; (b) NaH, THF, 23 “C, then com- 
pound 10, 23 “C; (c) NaBH,, 
CeCl,*7H,O, MeOH, -78 “C --t -20 “C; 
(d) TBAF, then separation of stereoiso- 
mers; (e) CICO,CH,CCI,, 2,6-lutidine, 
CHzCI,, 23 “C; (f) HCI (anhyd.), MeOH, 
23 “C, 6 h; (g) Me,S, benzoyl peroxide 
(BPO), MeCN, 0 “C; (h) 1 M LiOH, THF, 
23 “C. 
15 16 (R = CI,CCHZ-1 
17 18 19 
yield. All three operations were carried out in one reac- 
tion vessel without isolation of any intermediates. 
Treatment of compound 21 with ten equivalents of 
mercuric chloride in the presence of excess calcium car- 
bonate gave mono-protected epoxide 22 in 73 % yield. 
By using a larger excess of mercuric chloride, depudecin 
1 was isolated in 52 % yield (Fig. 3).The structure of syn- 
thetic depudecin was identical to that of natural 
depudecin, which was kindly provided by Drs Shigeru 
Matsutani, Hitoshi Arita, and Toshiyuki Kamigauchi of 
Shionogi Research Laboratories, as judged by comparison 
of optical rotation ([01]23D -31” (c = 0.080, CHCl,), lit. 
L91: [423D -35.8” (c = 0.52, CHCl,)), infrared, ‘H, and 
13C NMR spectra. We therefore conclude that the first 
total synthesis of (-)-depudecin has been achieved. The 
synthesis proceeds in 22 total steps and in 1.4 % overall 
yield. The one-pot stereoselective conversion of syn- 
vicinal diols into trans-epoxides efficiently constructs the 
two epoxide moieties simultaneously, and should prove 
valuable in the synthesis of depudecin-related molecules 
that may facilitate the isolation and characterization of 
the cellular target(s) of depudecin. 
The synthetic studies described above addressed our first 
challenge - to access samples of depudecin. We are 
now attempting to modify the synthetic pathway to 
produce radiolabeled and immobilized derivatives to 
facilitate the purification of proteins that interact with 
depudecin. To identify structural elements that might be 
modified without a loss in activity, and to develop an 
experimental system to investigate the depudecin-sensi- 
tive signaling pathway, we analyzed the effect of syn- 
thetic depudecin and its derivatives on NIH3T3 cells 
transformed with v-Ha-ras. These and other cells trans- 
formed by oncogenes acquire abnormal phenotypes 
resulting from constitutively activated pathways impor- 
tant in the control of cell growth, shape, and mobility. 
Examples of such abnormal phenotypes are cell growth 
without contact inhibition, round or spindle cell shape, 
loss of actin stress fibers, and anchorage-independent 
Fig. 3. Synthesis of (-)-depudecin 1 by a 
procedure that efficiently constructs the 
two epoxide moieties simultaneously. 
Reagents and conditions: (a) MeC(OMe)s, 
cat. PPTS, 23 “C; (b) trimethylsilyl chlo- 
ride (TMSCI), triethylamine (TEA), 23 “C; 
Cc) K,CO,, MeOH, 23 “C; (d) 10 ea. 
HgCI&aCOs, MeCN-H@, 23 “C, 3.5 
h; (e) 50 eq. HgCIz-CaCO,, MeCN-H,O, 
23 “C, 3.5 h. 
MTMO HO 
HO OH OMTM 
19 20 
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MTMO OH 
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Fig. 4. Restoration of actin stress fibers in v-Ha-ras-transformed NIH3T3 and MG63 cells by treatment with synthetic (-)-depudecin. Actin 
stress fibers and nuclei in cells grown on slide cover slips were stained with both FITC-phalloidin (green) and propidium iodide (red). (a) 
Control v-Ha-ras-transformed NIH3T3 cells; (b) v-Ha-ras-transformed NIH3T3 cells treated with 4.7 FM synthetic (-)-depudecin; (c) 
Control MC63 cells; (d) MG63 cells treated with 4.7 )IM synthetic (-)-depudecin. (Bar = 10 pm) 
growth [25,26]. Since depudecin has been shown to 
alter the shape of oncogene-transformed cells, it proba- 
bly affects other processes related to cellular transforma- 
tion. We therefore selected a cell-staining assay that 
would provide insight into the effects of synthetic 
depudecin and its structural variants on the cytoskeleton 
as well as on the shape of cells. 
Double staining for actin stress fibers and for nuclei 
using fluorescein isothiocyanate (FITC)-labeled phal- 
loidin and propidium iodide, respectively, showed that 
the v-Ha-rus-transformed cells have a spindle-like 
morphology and that they lack the network of actin 
stress fibers (Fig. 4a) that are present in the parent 
NIH3T3 cell line (data not shown). Following incuba- 
tion with synthetic depudecin (4.7 PM) for 24 h at 
37 “C, the morphology of the transformed cells 
reverted to a flattened shape, similar to that of the 
parent cell line NIH3T3, and the actin stress fibers 
reappeared (Fig. 4b). Th ere was no significant change 
in the shape of nuclei (Fig. 4). In contrast to synthetic 
depudecin, the mono-methylthiomethyl-protected 
depudecin 22 showed only a weak reversion activity 
even at 10 times higher concentration (47 ~.LM, data 
not shown), and the bis-methylthiomethyl-protected 
depudecin 21 and bis-protected tetraol 19 had no 
activity at the same concentration (47 p,M, data not 
shown). These results suggest that the epoxide and 
hydroxy groups are essential for the detransforming 
activity of depudecin. The possibility that the actions of 
depudecin are antagonized by analogs that do not 
exhibit activity was also examined. Treatment of cells 
with -20-fold molar excess of each inactive compound 
relative to depudecin did not result in antagonism by 
any of the inactive analogs (Table 1). This implies that 
the inactive compounds do not competitively bind to 
or modify the site on the target protein(s) that mediates 
the effects of depudecin. 
To obtain an understanding of the mechanism under- 
lying morphological reversion by depudecin, we exam- 
ined the effects of several cell-permeable inhibitors on 
depudecin-mediated reversion of v-Ha-rus-transformed 
NIH3T3 cells (Table 1). Simultaneous addition of actin- 
omycin D (an inhibitor of RNA synthesis) and cyclo- 
heximide (an inhibitor of protein synthesis) with 
synthetic depudecin abolished both the morphological 
change and formation of bundles of actin microfila- 
ments. On the other hand, morphological change by 
synthetic depudecin was not interrupted by hydroxyurea 
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Table 1. Actin stress fiber restoration by synthetic depudecin 
(compound 1) and its structural variants in v-Ha-ras- 
transformed NIH3T3 cells. 
Activity 
Treatment 0.47 4.7 9.4 23.5 47 100 (PM) 
Compound 
1 -a + + ++ +++ ND 
22 - - - - f + 
21 - - - - 
19 - - - - 
lb+21 (IOOpM) + 
1 + 19 (100 PM) + 
1 + Hydroxyurea (1 mM) + 
1 + Actinomycin D (1 pg ml-‘) - 
1 + Cycloheximide (1 mM) - 
1 + FK506 (100 nM) + 
1 + Rapamycin (10 nM) ++ 
1 + Wortmannin (10 nM) ++ 
1 + Staurosporine (20 nM) + 
1 + Sodium vanadate (1 mM) + 
aActin stress fiber restoration activity: -, no effect; f, weak; +, 
moderate; ++, strong; +++, very strong; ND, not determined. 
b4.7 PM depudecin was used throughout for inhibition assays. 
(an inhibitor of DNA synthesis) [27], FK506 (an 
inhibitor of calcineurin) [28], staurosporine (a general 
inhibitor of protein kinases) [29] or sodium vanadate (a 
general inhibitor of protein phosphatases) [30]. These 
results indicate that the induced transcription of a gene 
or genes followed by de novo protein synthesis is 
required for the reversion activity of synthetic 
depudecin. Depudecin may therefore interact with or 
block the function of a target protein that suppresses 
the expression of anti-Ras or anti-tumor activity. 
Interestingly, rapamycin (an inhibitor of the FKBP- 
rapamycin-associated protein (FRAP)) [31] and wort- 
mannin (an inhibitor of phosphatidyl inositol 3-kinase 
(PI3K)) [32] apparently enhance the flat reversion activ- 
ity of synthetic depudecin. This also implies that the 
target molecule of depudecin does not participate in the 
PI3K and FRAP-mediated p70s6 kinase signaling 
pathway, and that the cooperative interruption of differ- 
ent growth signaling pathways may result in a synergistic 
effect on detransformation. 
We also analyzed the effect of synthetic depudecin on 
the morphology of a human osteosarcoma cell line 
(MG63), and found that it induced well organized actin 
stress fibers, as seen in a comparison to non-treated cells 
(Fig. 4c,d). This cell line is derived from a tumor, and 
therefore was not transformed by the laboratory intro- 
duction of a specific oncogene, as is the case for the 
v-Ha-ras-transformed NIH3T3 cells described above. 
Sugita et al. have reported that natural depudecin 
induces reversion of the flat phenotype of cells trans- 
formed with the oncogene raf[lO].The protein product 
of raf; Raf-1, acts as a downstream mediator of the Ras 
signal [33]. Together with our data, the results suggest 
that depudecin may interact with a target protein 
common to multiple cell types and that its ability to 
induce stress fibers does not require transformation with 
rus. Recent studies of growth-factor-mediated actin 
stress fiber formation in Swiss 3T3 cells suggest that 
whereas signaling through Ras is not required, signaling 
through the related small GTPases Rat and Rho is 
essential [34]. Sequential elements of the pathway 
include growth factor receptors, PI3K, Rat, arachidonic 
acid formation and conversion to leukotrienes, 
leukotriene-dependent Rho activation, and stress fiber 
formation. The identification of the depudecin-binding 
protein(s) and others whose activities are modulated by 
depudecin should advance the findings in this work and 
promote our understanding of the molecular mechanism 
of this signaling pathway. 
Significance 
The detransformation agent depudecin appears 
to be a valuable probe of signaling pathways 
regulating the formation of actin stress fibers. It 
is not easily obtained, however, and many exper- 
iments aimed at investigating the depudecin- 
sensitive signaling pathways will require 
synthetic derivatives of depudecin. Using a total 
of 22 synthetic transformations, we have 
achieved a total synthesis of the natural (-)-form 
of depudecin that provides ample quantities of 
the compound for mechanistic investigations 
and that should be easily modified to prepare 
derivatives useful in identifying the protein 
receptor(s) of depudecin. We report a cell stain- 
ing assay that reveals the ability of synthetic 
depudecin not only to alter the spindle-shaped 
morphology of v-Ha-rus-transformed NIH3T3 
cells to a flattened shape, but also to induce an 
intricate actin stress fiber network in these cells 
and in MG63 osteosarcoma cells. Depudecin- 
mediated stress fiber formation appears to 
require the induced transcription of genes and 
subsequent de noun protein synthesis. These find- 
ings create a framework for studies that will 
illuminate the growth factor-mediated signaling 
pathways leading to stress fiber formation. 
Materials and methods 
Synthetic conditions 
Melting points were measured with a Mel-Temp apparatus and 
are uncorrected. Infrared spectra (IR) were recorded using a 
Nicolet 5PC FT-IR spectrometer (y max in cm-‘). Samples 
were prepared as thin films by evaporation onto a salt plate 
(NaCl) or as solutions in noted solvents using a NaCl solution 
cell. ‘H NMR spectra were recorded on either a Bruker AM- 
500 (500 MHz) or AM-400 (400 MHz) spectrometer as noted 
at ambient temperature. Data were reported as follows: chemi- 
cal shifts in parts per million (ppm) using residual protio 
solvent as internal standard (7.26 for CDCl,) on the 6 scale, 
multiplicity (br = broad, s = singlet, d = doublet, t = triplet, q 
= quartet, quin = quintet, m = multiplet), coupling constant(s) 
in Hz, and integration. 13C NMR spectra were recorded on a 
Brucker AM-400 (100 MHz) spectrometer and were reported 
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in ppm using solvent resonance as internal standard (77.0 for 
CDCI,). All 13C spectra were determined with complete 
proton decoupling. Mass spectra were obtained using either a 
JEOL AX-505 or SX-102. Optical rotations were measured 
using a Perkin-Elmer 241 polarimeter at 23 “C using a sodium 
lamp (589 nm) and are reported in degrees with concentration 
in units of 10 mg ml-‘. 
Cells and cell culture conditions 
v-Ha-ras-transformed NIH3T3 cells were kindly supplied by 
R.L. Erikson of the Department of Molecular and Cellular 
Biology, Harvard University, and were cultured at 37 “C in a 
humidified atmosphere of 5 % CO, in Dulbecco’s modified 
minimal Eagle’s medium supplemented with 10 % fetal calf 
serum (FCS). MG63 cells were cultured in RPM1 1640 + 10 % 
FCS using the same culture conditions used with v-Ha-rus- 
transformed NIH3T3 cells. 
Double staining of actin stress fibers and nuclei with 
FITC-phalloidin and propidium iodide 
For observation of actin stress fibers and nuclei by fluo- 
rescence microscopy, cells were stained with both FITC- 
phalloidin and propidium iodide according to the method of 
Hall et al. [35]. Briefly, asynchronous cells were cultured on a 
slide cover slip for 18 h. After treatment with depudecin or 
related molecules for an additional 24 h, cells were fixed with 
3.7 % paraformaldehyde in phosphate-buffered saline (PBS) 
for 20 min at room temperature. Following 3x washing with 
PBS, cells were treated with 0.1 % Triton X-100 in PBS for 5 
min to increase cell permeability. Next, the cells were treated 
with FITC-phalloidin (2.5 p,g ml-‘, Sigma) for 20 min and, 
after 3x washing with PBS, the cells were mounted on a slide 
with antifader (1,4-diazabicyclo[2.2.2]octane, Aldrich) con- 
taining propidium iodide (0.1 kg ml-’ in 50 % glycerol). Cells 
were inspected by conventional fluorescence microscopy 
(Leica, Germany). 
Selected experimental procedures for the synthesis of 
depudecin and synthetic intermediates follow (a complete 
listing of experimental procedures and spectroscopic data are 
available from the authors upon request). 
Synthesis of (2R, 3S, SE, 7S, SS, 9R)-2,3:8,9-O-bis- 
isopropylidene-7-tert-butyldimethylsiloxyundeca-5,1 O- 
dien-4-one (compound 13) 
To a suspension of NaH (60 % in mineral oil, 115 mg, 
2.89 mmol) in THF (3 ml) was added dropwise a solution of 
the phosphate 12 (885 mg, 3.32 mmol) inTHF (3 ml) at 0 “C. 
After stirring for 5 min at ambient temperature, to the mixture 
was added a solution of the aldehyde IO (666 mg, 2.22 mmol) 
in THF (3 ml). The reaction was stirred for additional 2 h at 
ambient temperature, quenched with water (5 ml) and 
extracted into Et,O. The combined organic extracts were 
washed with brine, dried over MgSO, and concentrated. 
Purification by flash chromatography (eluent: 6.25 % ethyl 
acetate:hexane) gave 861 mg (88 %) of compound 13 (iso- 
merit mixture) as a colorless oil: IR (thin film) : 2988, 2957, 
2934,2888,2859, 1696, 1630, 1381, 1372, 1254, 1171,1125, 
1100, 1069, 986, 837 cm-‘; ‘H NMR (500 MHz, CDCl,) 6 
7.12 (dd, 1x4/5 H,j = 4.1, 15.7 Hz, C,-H), 6.99 (dd, 1x1/5 
H,_I = 4.2, 15.7 Hz, C,-H), 6.89 (dd, 1x4/5 H,_J = 1.8, 15.7 
Hz, C,-H), 6.85 (dd, 1x1/5 H,] = 1.8, 15.7 Hz, C,-H), 5.81 
(ddd, 1x4/5 H,] = 6.5, 10.4, 17.0 Hz, C,,-H), 5.76 (ddd, 
1x1/5 H,] = 6.4, 10.4, 17.0 Hz, C,,-H), 5.34 (td, 1x4/5 H,j 
= 1.3, 17.0 Hz, C,,-H), 5.30 (td, 1x1/5 H,] = 1.4, 17.0 Hz, 
Cl,+), 5.21 (td, 1x4/5 H,] = 1.1,10.4 Hz, C,,-H), 5.18 (td, 
1x1/5 H,j = 1.1, 10.4 Hz, C,,-H), 4.58 (brdt, 1x4/5 H,_I = 
1.8,4.4 Hz, C,-H),4.56 (dt, 1x1/5 H,j= 1.8,4.1 Hz, C,-H), 
4.44 (brdd, 1x1/5 H,j= 6.4,7.7 Hz, C,-H), 4.26 (brdd, 1x4/5 
H,j= 6.5,7.9 Hz,C,-H),4.11-4.01 (m,2 H,C,-H,C,-H), 
3.79 (dd, 1x4/5 H,J = 4.9,7.9 Hz, C,-H), 3.75 (dd, 1x1/5 H, 
j = 4.1, 7.7 HZ, C,-H), 1.46, 1.43, 1.42, 1.39 (s, 3 H, ace- 
tonide), 1.40 (d, 3 H,j = 6.0 Hz, Cl-H), 0.94 (s, 9x1/5 H, trrt- 
BuSi), 0.92 (s, 9x4/5 H, terf-BuSi), 0.11 (s, 3x1/5 H, CH,Si), 
0.08 (s, 3x4/5 H, CH,Si), 0.06 (s, 3x4/5 H, CH,Si), 0.04 (s, 
3x1/5 H, CH,Si); 13C NMR (100 MHz; CDCl,) 6 197.6, 
147.8 (minor), 147.1 (major), 136.1 (minor), 135.9 (major), 
124.9 (major), 124.4 (minor), 117.9, 110.2 (major), 110.0 
(minor), 109.5,86.0 (major), 85.91 (minor), 82.8, 78.3 (major), 
77.8 (minor), 74.6 (major), 74.4 (minor), 71.8 (minor), 71.7 
(major), 27.2 (major), 27.2 (minor), 27.0 (major), 26.9 (minor), 
26.8 (major), 26.2 (minor), 26.2 (major), 25.9 (minor), 25.7, 
18.5 (major), 18.4 (minor), -4.6 (minor), -4.8 (major); high 
resolution mass spectrometry (HRMS) (CI NH,) m/e calc’d 
for CZ3H,,N0,Si 458.2939 [(M+NH4)+], found 458.2938. 
Synthesis of (2R, 3S, 4S, SE, 7S, SS, 9R)-2,3:8,9-O-bis- 
isopropylidene-7-tert-butyldimethylsiloxy-undeca-5,7 O- 
dien-4-o/ (compound 14) 
To a stirred solution of compound 13 (200 mg, 0.454 mmol, 
8:2 isomeric mixture) and CeC13*H,0 (846 mg, 2.27 mmol) 
in MeOH (6.5 ml) was added NaBH4 (51 mg, 1.36 mmol) at 
-78 “C. The reaction was stirred for 20 min at -78 “C, then 
slowly warmed to -10 “C over 1 h and quenched with water 
(20 ml). The product was extracted into Et,O. The combined 
organic extracts were washed with brine, dried over MgSO, 
and concentrated. Purification by flash chromatography 
(eluent: 20 % ethyl acetate:hexane) gave 193 mg (96 %) of 
compound 14 (about 75 % isomeric purity) as a colorless oil: 
IR (thin film) 3500 (br), 2986,2934,2859, 1379, 1372, 1252, 
1217,1173,1123,1092,1067,837 cm-‘; ‘H NMR (400 MHz, 
CDCl,) 6 5.91 (dd, 1 H,J = 5.5,15.6 Hz, C,-H), 5.83 (ddd, 1 
H,_I = 6.8, 10.4, 17.2 Hz, C,()-H), 5.75 (dd, 1 H,_I = 7.3, 15.6 
Hz, C,-H ), 5.33 (td, 1 H,J = 0.8, 17.2 Hz, C,,-H), 5.19 (td, 1 
H,J = 0.8, 10.4 Hz, C,,-H), 4.37-4.33 (m, 2 H, C,-H, 
C,-H),4.11 (brq, 1 H,j= 5.5 Hz,C,-H),4.03 (dq, 1 H,J= 
6.0,8.1 Hz, C,-H), 3.70 (dd, 1 H,J = 4.4,8.0 Hz, C,-H), 3.50 
(dd, 1 H,_I = 4.5,8.1 Hz, C,-H), 2.28 (d,j = 6.2 Hz), 1.40 (s, 6 
H, acetonide), 1.40 (s, 3 H, acetonide), 1.39 (s, 3 H, acetonide), 
1.28 (d, 3 H,] = 6.0 Hz, Cl-H), 0.89 (s, 9 H, tert-BuSi), 0.06 
(s, 3 H, CH,Si), 0.05 (s, 3 H, CH,Si); 13C NMR (100 MHz; 
CDCl,) 6 136.3, 131.6, 130.6, 117.7, 109.2, 108.6, 85.1, 83.7, 
78.1, 73.3, 71.9, 71.5, 27.5, 27.1, 27.0, 27.0, 25.9, 18.3, -4.4, 
-4.7; HRMS (CI NH,) m/e calc’d for C,,H,,NO,Si 460.3096 
[(M+NH,)+], found 460.3099. 
Synthesis of (4S, 5S)-4-L(E)-2-[(4R, SRI-S-1(7 R)- 7 -hydroxy- 
ethyl]-2-oxo- 7,3-dioxolan-4-yllethenyll-5-[(7S)- 7 - 
hydroxy-2-propenyll- 7,3-dioxolan-2-one (compound 17) 
To a solution of compound 16 (227 mg, 0.334 mmol) in 
MeOH (4.6 ml) was added methanolic hydrogen chloride 
solution (2.3 ml, -15 % w/w) at 0 “C. The reaction was 
stirred for 6 h at ambient temperature and concentrated.The 
residue was subjected to flash chromatography (eluent 
72.5 % ethyl acetate:hexane) to yield compound 17 
(44.2 mg, 44 %) as a colorless oil: [a]23D -109.0” (c = 1.74, 
CH,OH); IR (thin film) 3443 (br), 2982, 1788, 1375, 1183, 
1067,978,860 cm-*; ‘H NMR (400 MHz, CD,OD) 6 6.09 
(m, 2 H, C,-H, C,-H), 5.89 (ddd, 1 H,J = 6.1, 10.6, 17.0 
Hz, C,,-H), 5.44 (td, 1 H,J = 1.2, 17.0 Hz, C,,-H), 5.31 
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(td, 1 H,J = 1.1, 10.6 Hz, C,,-H), 5.16-5.11 (m, 2 H, 
C,-H, C,-H), 4.47 (dd, 1 H,J = 3.6, 5.8 Hz, C,-H), 4.35 
(dd, 1 H,J = 2.8,6.1 Hz, C,-H), 4.29-4.27 (m, 1 H, C,-H), 
3.87 (dq, 1 H,j = 2.8, 6.5 Hz, C,-H), 1.26 (d, 3 H,_I = 6.5 
Hz, C,-H); 13C NMR (100 MHz; CD,OD) 6 156.3, 156.1, 
136.4, 131.7, 131.7, 118.8,85.7,84.4,79.0,78.6,72.4,67.0, 
18.8; HRMS (CI NH,) m/e calc’d for Cj3H,,N0, 318.1189 
[(M+NH,)+], found 318.1199. 
Synthesis of (4S, 5S)-4-l(E)-2-1(4R, SR)-S-1(1 R)- l- 
(methylthiomethoxy)ethyl]-2-oxo- 1,3-dioxolan-4-y/1- 
ethenyl]-5-[(IS)- 7 -methylthiomethoxy-2-propenyll- 7,3-d;- 
oxolan-2-one (compound 18) 
To a solution of diol 17 (38 mg, 0.127 mmol) in MeCN 
(1.3 ml) at 0 “C was added Me,S (0.223 ml, 3.04 mmol) fol- 
lowed by the portionwise addition of benzoyl peroxide 
(368 mg, 1.52 mmol) over a 5 min period.After stirring for 3.5 
h at 0 “C, the mixture was quenched by the addition of satu- 
rated aqueous NaHC03 solution and extracted with CHCl, 
(2 ml) 3x. The combined organic extracts were successively 
washed with 5 M aqueous Na,S,O, solution and brine, dried 
over Na$O, and concentrated. Purification by flash chro- 
matography (eluent: 35 % ethyl acetate:hexane) gave 17.8 mg 
(34 %) of 18 as a colorless oil: [c@3D -252” (c = 1.36, CHCI,); 
IR (thin film) 2922, 1796, 1051 cm-‘; ‘H NMR (400 MHz, 
CDCl,) S 5.98 (m, 2 H, C,-H, C,-H), 5.78 (ddd, 1 H,J = 7.4, 
10.4, 17.7 Hz, C,,-H), 5.72 (d, 1 H,] = 10.4 Hz, C,,-H), 5.48 
(td, 1 H,j = 1.0, 17.7 Hz, C,,-H), 5.09 (ddd, 1 H,J = 1.3,2.7, 
5.5 Hz, C,-H), 5.06 (ddd,J = 1.3,2.5,4.9 Hz, C,-H), 4.80 (d, 
1 H,j = 11.9 Hz,-OC&SCH,), 4.79 (d, 1 H,J = 12.0 Hz, 
-OCH,SCH,), 4.59 (d, 1 H,j = 12.0 Hz, -OC&SCH,), 4.53 
(d, 1 H,j = 11.9 Hz, -OCI&SCH,), 4.40-4.35 (m, 2 H, 
C,-H,C,-H),4.31 (dd, 1 H,j= 3.0,5.5 Hz,C,-H),3.94 (dq, 
1 H,j = 3.0,6.5 Hz, C,-H), 2.170 (s, 3 H, SCH,), 2.166 (s, 3 
H, SCH,), 1.28 (d, 3 H,j = 6.5 Hz, C,-H); 13C NMR (100 
MHz; CDCl,) 6 153.8, 153.7,130.9,129.3, 129.2, 123.1,82.7, 
81.6, 76.5, 76.3, 75.5, 73.7, 73.1, 70.3, 14.4 (X2), 14.36; 
HRMS (FAB, m-nitrobenzylalcohol, added NaI) m/e calc’d for 
C1,HZ408S2Na 443.0804 [(M+Na)+], found 443.0797. 
Synthesis of (2R, 3S, 4S, SE, 7S, SS, 9R)-2,9-di(methylthio- 
methoxylundeca-5, IO-dien-3,4,7,8-tetraol (compound 19) 
To a solution of compound 18 (27.1 mg, 0.0644 mmol) in THF 
(4 ml) was added 0.38 ml (0.38 mmol) of aqueous 1 M LiOH 
solution at ambient temperature. After stirring for 1.5 h at 
ambient temperature, the reaction was quenched by the addi- 
tion of phosphate buffer (PH 7.0) and extracted into CHCI,-2- 
PrOH (5:1).The combined extracts were dried over Na,SO, 
and concentrated. Purification by flash chromatography (eluent: 
5 % MeOH/CHC13) gave compound 19 (22.1 mg, 93 %) as 
slightly yelIowish needles: melting point 99-100 “C; [o12jD 
-202” (c = 0.990, CHCl,); IR (thin fihn) 3420 (br), 2978,2920, 
1429, 1300, 1053,978 cm-*; ‘H NMR (400 MHz, CDCI,) 6 
5.91 (m, 2 H,C,-H, C,-H), 5.78 (ddd, 1 H,J= 8.0, 11.6,18.7 
Hz, C,,-H), 5.40 (td, 1 H,j = 1.0 , 11.6 Hz, C,,-H), 5.38 
(ddd, 1 H,j = 0.9,1.3,18.7 Hz, C,,-H), 4.76 (d, 2 H, J = 11.7 
Hz, -OCH2SCH3(X2)), 4.60 (d, 1 H, 1 = 11.7 Hz, 
-OC&SCH,), 4.54 (d, 1 H,J = 11.7 Hz, -OCQSCH,), 4.28 
(dd, 1 H,_I = 5.2, 8.0 HZ, C-H), 4.26-4.22 (m, 2 H, C,-H, 
CT--H), 3.94 (dq, 1 H,_T = 4.2, 6.3 Hz, C,-H), 3.50 (m, 1 H, 
C,-H), 3.35 (m, 1 H, C,-H), 2.82 (d, 1 H,J = 4.3 Hz, OH), 
2.74 (d, 1 H,J = 4.8 Hz, OH), 2.71 (d, 1 H,J = 5.4 Hz, OH), 
2.68 (d, 1 H,J= 5.9 Hz, OH), 2.18 (s,3 H,SCH,), 2.17 (s,3 H, 
SCH,), 1.24 (d, 3 H,j = 6.3 Hz, C,-H); 13C NMR (100 MHz; 
CDCl,) 6 134.0, 132.1, 131.9, 121.0, 78.5, 77.1, 75.8, 73.4 
(X2), 72.8, 72.2, 71.6, 15.8 (X2), 14.5; HRMS (FAB, m- 
nitrobenzylalcohol, added NaI) m/e calc’d for C15H2806S2Na 
391.1225 [(M+Na)+], found 391.1224. 
Synthesis of (ZR, 3S, 4S, SE, 7S, 8S, 9R)-2,9-di(methyl- 
thiomethoxy)-3,4,7,8-diepoxyundeca-S, l O-diene 
(compound 21) 
A solution of pyridinium p-toluenesulfonate (0.02 M in 
CH,Cl,, 82.0 ml, 1.63 mmol) was added to a solution of the 
tetraol 19 (15.0 mg. 40.8 mmol) and trimethylorthoacetate 
(156 ml, 1.22 mmol) in CH,Cl, (1 ml) at ambient temperature. 
After 25 min, the volatiles were evaporated and residual MeOH 
was removed under high vacuum (0.1 mm Hg) for 2 min. After 
addition of triethylamine (0.02 M in CH,Cl,, 0.41 ml, 
8.2 mmol) and CH,Cl, (1 ml), the solution was cooled to 
-30 “C and chlorotrimethyisilane (0.5 M in CH,CI,, 0.82 ml, 
0.41 mmol) was added dropwise. The reaction was stirred for 
1.5 h at 0 “C then for 2 h at ambient temperature.The solution 
was evaporated in vacua to yield the crude diacetoxy dichloride 
20. Physical data of 20 (obtained from a similar experiment as 
colorless needles by flash chromatography (eluent: 20 % ethyl 
acetate:hexane)): IR (thin film) 2978, 1750, 1431, 1372, 1223, 
1034,978 cm-‘; ‘H NMR (400 MHz, CDCl,) S 5.94-5.84 (m, 
2 H, C,-H, C,-H), 5.60 (ddd, 1 H,j = 7.5, 9.7, 17.8 Hz, 
C,,-H), 5.40 (td, 1 H, /= 1.1 , 17.8 Hz,C,,-H), 5.40 (td, 1 H, 
J = 1.1,9.7 Hz, C,,-H), 5.22 (dd, 1 H, _I = 4.7.7.0 Hz, C,-H), 
5.12 (dd, 1 H,l= 3.7,7.8 Hz, C-H), 4.77 (d, 1 H,J= 11.7 Hz, 
-OCH,SCH,), 4.76 (d, 1 H,J = 11.7 Hz, -OCI-I,SCH,), 4.65 
(d, 1 H,_I = 11.7 Hz,-OCB,SCH,), 4.60 (m, 1 H, C,-H), 4.59 
(m, 1 H, C,-H), 4.54 (dd, 1 H,j = 4.7,7.5 Hz,C+H), 4.52 (d, 1 
H,_T = 11.7 Hz, -OCEI,SCH,), 3.66 (dq, 1 H,j = 3.7,6.4 Hz, 
C,-H), 2.18 (s, 3 H, SCH,), 2.17 (s, 3 H, SCH,), 2.13 (s, 3 H, 
OAc), 2.10 (s, 3 H, OAc), 1.14 (d, 3 H,j = 6.4 Hz, Cl-H); 13C 
NMR (100 MHz; CDCl,) 6 169.8, 132.7, 131.6, 131.2, 121.6, 
77.3,75.9,74.8,73.5,72.6,70.1,57.32,57.27,20.92,20.87,15.7, 
14.2, 14.1; HRMS (CI NH,) m/e calc’d for C,,H,,NO,S,Cl, 
506.1207 [(M+NH4)‘], found 506.1225. Potassium carbonate 
(22.5 mg, 0.163 mmol) was added in one portion to the solution 
of the crude diacetoxy dichloride 20 in MeOH (1 ml) and the 
suspension stirred vigorously for 2.5 h.The mixture was filtered, 
the filtrate evaporated in vacua and the residue purified by flash 
chromatography (eluent: 20 % ethyl acetate:hexane) to yield 
compound 21 (10.0 mg, 74 %) as a slightly yellowish oil: [(Y]~~,, 
-28” (c = 0.55, CHCl,); IR (thin film) 2978,2921, 1433, 1300, 
1049,963,887 cm-‘; ‘H NMR (400 MHz, CDCl,) d 5.75 (ddd, 
1 H,_I = 7.0, 10.5, 17.3 Hz, C,,-H), 5.66 (m, 2 H, C,-H, 
C,-H), 5.36 (td, 1 H,_T = 1.3 , 17.3 Hz, C,,-H), 5.33 (td, 1 H,_I 
= 1.2, 10.5 Hz, C,,-H), 4.78 (d, 1 H, _I = 11.5 Hz, 
C,-OCH,SCH3), 4.76 (d, 1 H,I = 11.5 Hz, C,-OCII,SCH,), 
4.72 (d, I H,j = 11.5 Hz, C,-OC&SCH,), 4.62 (d, 1 H,J = 
11.5 Hz, C,-OCI&SCH,), 4.11 (dd, 1 H,_I = 5.9, 7.0 Hz, 
C,-H), 3.66 (quin, 1 H,j = 6.5 Hz, C,-H), 3.29 (dt, 1 H,_I = 
2.2, 4.4 Hz, C,-H), 3.19 (dt, 1 H,] = 2.2,4.5 Hz, C4-H), 3.01 
(dd, 1 H,_I = 2.2,5.9 Hz, C,-H), 2.92 (dd, 1 H,_I = 2.2,6.5 Hz, 
C,-H), 2.15 (s, 6 H, SCH,), 1.54 (d, 3 H,j = 6.5 Hz, C,-H); 
13C NMR (100 MHz; CDCI,) 6 133.2, 132.1, 131.8, 119.7, 
76.6, 73.5, 72.8, 72.5, 63.2, 61.6, 54.2, 53.9, 17.0, 13.9, 13.8; 
HRMS (FAR, m-nitrobenzylalcohol, added NaI) m/e cak’d for 
C,sHz.+O,S,Na 355.1015 [(M+Na)+],found 355.1010. 
Synthesis of (2R, 3S, 4S, 5E, 7S, SS, 9R)-g-methyl- 
thiomethoxy-3,4,7,8-diepoxyundeca-5, IO-dien-2-o/ 
(compound 22) 
To a suspension of compound 21 (4.5 mg, 14 mmol) and 
CaCO, (18.0 mg, 0.180 mmol) in MeCN-HZ0 (4:1, 1.6 ml) 
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was added portionwise H&l, (32.6 mg, 0.120 mmol) at 
ambient temperature.The reaction was stirred for 5.5 h, diluted 
with 5M NH40Ac (1 ml) and filtered through a pad of celite. 
The filtrate was extracted with CHCl, 3x. The combined 
extracts were dried over Na,S04 and concentrated. Purification 
by flash chromatography (eluent: 50 % ethyl acetate:hexane) 
gave compound 22 (2.7 mg, 73 %) as a colorless oil: [a]23,, -79” 
(c = 0.10, CHCl,); IR (thin film) 3445,2974,2923,1431,1260, 
1144,1046,965,889 cm-‘; ‘H NMR (400 MHz, CDCl,) 6 5.76 
(ddd, 1 H,j = 6.7, 10.2, 17.3 Hz, C,,-H), 5.68 (m, 2 H, C,-H, 
C,-H), 5.37 (td, 1 H,j = 1.4 , 17.3 Hz, C,,-H), 5.33 (td, 1 H,] 
= 1.3, 10.2 Hz, C,,-H), 4.79 (d, 1 H, / = 11.5 Hz, 
C,-OCH,SCH,), 4.63 (d, 1 H,/ = 11.5 Hz, C,-OCH,SCH,), 
4.11 (dd, 1 H,j= 5.9,6.8 Hz, C,-H),3.73 (dq, 1 H,]= 4.6,6.4 
Hz, +H), 3.37 (ddd, 1 H,J = 2.2, 3.6, 5.5 Hz, C,-H), 3.30 
(ddd, 1 H,j = 2.2,3.6,5.6 Hz, C,-H), 3.01 (dd, 1 H,] = 2.2,5.5 
Hz, C,-H), 2.90 (dd, 1 H,_J = 2.2,4.6 Hz, C,-H), 2.16 (s, 3 H, 
SCH,), 1.79 (d, 1 H,J = 6.3 Hz,-OH), 1.30 (d, 3 H,J= 6.5 Hz, 
C,-H); 13C NMR (100 MHz; CDCl,) 6 133.2, 131.9, 131.8, 
119.7,72.8 (X2), 67.0,64.1,61.7,55.4,54.3,20.1,13.8;HRMS 
(CI NH,) m/e calc’d for C,,H,,O,S 273.1161 [(M+H)‘], 
found 273.1173. 
Synthesis of (2R, 3S, 4S, 5E, 7S, SS, 9R)-3,4,7,8- 
diepoxyundeca-5,7 O-dien-2,9-dial ((-)-depudecin) 
(compound 1) 
To a suspension of compound 21 (3.9 mg, 12 mmol) and 
CaC03 (88 mg, 0.88 mmol) in MeCN-H20 (4:1, 1.6 ml) was 
added portionwise HgCl, (159 mg, 0.59 mmol) at ambient 
temperature.The reaction was stirred for 2.5 h, diluted with 5M 
NH40Ac (1 ml) and filtered through a pad of celite.The filtrate 
was extracted with CHCl, three times.The combined extracts 
were dried over Na2S0, and concentrated. Purification by flash 
chromatography (eluent: 3 % MeOH/CHC&) gave compound 
1 (1.6 mg, 52 %) as a colorless oil: [(w]~~,, -31” (c = 0.080, 
CHCl,) (lit.[9] [a]23D -35.8” (c = 0.52, CHCl,)); IR (CHCl,) 
3592,2990, 1605,1455,1381,965,893 cm-l; ‘H NMR (400 
MHz, CDCl,) 6 5.93 (ddd, 1 HJ = 5.5, 10.6,17.3 Hz, C,,-H), 
5.70 (m, 2 H, C,-H, C,-H), 5.39 (td, 1 H,J= 1.4, 17.3 Hz, 
C,,-H), 5.27 (td, 1 H,j= 1.4, 10.6 Hz, C,,-H), 4.13 (m, 1 H, 
C-H), 3.74 (dq(br), 1 H,]= 4.5,6.5 Hz, C,-H), 3.42 (ddd, 1 
H,] = 2.2,3.5,5.6 Hz, C,-H), 3.38 (ddd, 1 H,j = 2.2,3.5,5.6 
Hz, C,-H), 3.01 (dd, 1 H,] = 2.2,4.3 Hz, C,-H), 2.90 (dd, 1 
H,J = 2.2,4.5 Hz, C,-H), 1.94 (d, 1 H,j = 6.3 Hz, -OH), 1.80 
(d, 1 H,j = 6.0 Hz, -OH), 1.30 (d, 3 H,] = 6.5 Hz, Cl-H); 13C 
NMR (100 MHz; CDCl,) 6 136.2, 132.1, 131.6, 117.2, 71.6, 
67.0,64.2,62.5,55.4,55.0,20.1; HRMS (CI NH,) m/e calc’d 
for C,,H,,NO, 230.1392 [(M+NHh)+], found 230.1390. 
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